Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP-1s and Lean Mass: What the Research Shows Glucagon-like peptide-1 (GLP-1) receptor agonists have been making headlines for their dual role in managing type 2 diabetes and facilitating weight loss
While all three have some similarities in their mechanisms of action, potency, and potential outcomes from a clinical perspective, they also have some significant differences in terms of selectivity and side effects
For instance, in September 2025, Pfizer announced plans to acquire Metsera, entering into a definitive agreement
Lorch, MD, Assistant Professor of Ophthalmology at Harvard Medical School and comprehensive ophthalmologist at Massachusetts Eye and Ear
Similar content being viewed by others Research insights What is currently known about this topic
This medication not only helps with weight loss but also addresses underlying metabolic conditions that can make losing weight more difficult
US$ 24.98
US$ 28.88
US$ 25.40
US$ 23.11
US$ 24.48
US$ 23.52
